• Living with Parkinson’s: Using the LID-Monitor

    Levodopa is one of the main medications used to treat symptoms of Parkinson’s. As Parkinson’s progresses the doses of levodopa needed to maintain control over symptoms increases.

    Learn More 
  • What is levodopa-induced dyskinesia?

    Levodopa is the most effective and commonly used drug for treating Parkinson’s. It is a chemical building-block that your body converts into dopamine.

    Learn More 
  • Finger Tapping May Differentiate Parkinson’s From Essential Tremor

    Essential tremor (ET) is a neurological disorder that causes involuntary and rhythmic shaking.

    Learn More 
  • Parkinson’s and statins: PD-Monitor in clinical study

    ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s.

    Learn More 
  • Finger tapping test and Parkinson’s

    Diagnosis of Parkinson’s can be difficult to confirm by conventional assessments – relying on the judgement of a clinician observing and rating a patient’s movements, or costly brain scans.

    Learn More 
  • Partners Wanted to Accelerate Development of Mild Cognitive Impairment Diagnostic Device

    ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia.

    Learn More 
  • How drawing on an iPad could lead to Alzheimer’s diagnosis

    Complex figure tests are widely used neuropsychological tests where participants are asked to reproduce a complicated line drawing, first by copying it freehand and then drawing it from memory.

    Learn More 
  • LID-Monitor to also ‘manage bradykinesia’ // China study

    Pair text with an image to focus on your chosen product, collection, or blog post. Add details on availability, style, or even provide a review.

    Learn More 
  • Global recognition for ClearSky Medical Diagnostics

    ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology.

    Learn More 
  • SCOR Innovation Podcast: Interview with Professor Smith

    ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest SCOR Innovation Podcast.

    Learn More 
  • ‘Lifesaver’ Smith recognised for Parkinson’s research

    Professor Stephen Smith has been hailed a ‘national lifesaver’ in recognition of his research into the diagnosis and treatment of Parkinson’s.

    Learn More 
  • https://www.clearskymd.com/smith-invited-parkinsons-uk-events/

    Dr Stephen Smith will be a speaker at the sell-out Parkinson’s UK 2017 Research Support Network Conference in Birmingham in October.

    Learn More